​

Illumina (ILMN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ILMN Stock Forecast

Illumina stock forecast is as follows: an average price target of $150.00 (represents a 12.27% upside from ILMN’s last price of $133.61) and a rating consensus of 'Buy', based on 22 wall street analysts offering a 1-year stock forecast.

ILMN Price Target

The average price target for Illumina (ILMN) is $150.00 based on 1-year price targets from 22 Wall Street analysts in the past 3 months, with a price target range of $195.00 to $58.00. This represents a potential 12.27% upside from ILMN's last price of $133.61.

ILMN Analyst Ratings

Buy

According to 22 Wall Street analysts, Illumina's rating consensus is 'Buy'. The analyst rating breakdown for ILMN stock is 0 'Strong Buy' (0.00%), 15 'Buy' (68.18%), 6 'Hold' (27.27%), 1 'Sell' (4.55%), and 0 'Strong Sell' (0.00%).

Illumina Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 10, 2025Eve BursteinBernstein$140.00$136.692.42%4.78%
Jan 02, 2025Vijay KumarEvercore ISI$180.00$130.9337.48%34.72%
Nov 06, 2024Catherine Ramsey SchulteRobert W. Baird$139.00$156.21-11.02%4.03%
Nov 05, 2024Kyle MiksonCanaccord Genuity$145.00$156.21-7.18%8.52%
Nov 05, 2024Luke SergottBarclays$145.00$156.21-7.18%8.52%
Oct 17, 2024Shubhangi GuptaHSBC$180.00$143.8925.10%34.72%
Aug 28, 2024Jasper HellwegArgus Research$150.00$131.4614.10%12.27%
Aug 16, 2024Narumi NakagiriDaiwa$154.00$130.0418.43%15.26%
Aug 15, 2024Sung Ji NamScotiabank$164.00$127.3328.80%22.75%
Aug 14, 2024Luke SergottBarclays$125.00$123.581.15%-6.44%
Aug 14, 2024Nick SetyanWedbush$58.00$123.58-53.07%-56.59%
Aug 13, 2024David WestenbergPiper Sandler$195.00$124.5456.58%45.95%
Aug 07, 2024Catherine Ramsey SchulteRobert W. Baird$124.00$125.39-1.11%-7.19%
Jul 30, 2024Dave WestenbergPiper Sandler$200.00$122.5063.27%49.69%
Jun 25, 2024Catherine Ramsey SchulteRobert W. Baird$119.00$110.247.95%-10.93%
Jun 11, 2024Vijay KumarEvercore ISI$175.00$110.9557.72%30.98%
Jun 06, 2024Doug SchenkelWolfe Research$175.00$111.7156.66%30.98%
Jun 04, 2024Kyle MiksonCanaccord Genuity$130.00$102.0627.38%-2.70%
Jun 03, 2024Tycho PetersonJefferies$115.00$104.2810.28%-13.93%
Apr 12, 2024Vijay KumarEvercore ISI$200.00$130.4853.28%49.69%
Aug 10, 2023Daniel AriasStifel Nicolaus$225.00$185.2021.49%68.40%
Feb 08, 2023Leerink Partners$250.00$215.7415.88%87.11%
Dec 12, 2022Citigroup$180.00$205.62-12.46%34.72%
Dec 07, 2022RBC Capital$282.00$205.9836.91%111.06%
Sep 29, 2022Vijay KumarEvercore ISI$250.00$193.8128.99%87.11%
Sep 05, 2022David WestenbergPiper Sandler$320.00$196.0763.21%139.50%
May 15, 2022David WestenbergPiper Sandler$360.00$233.5654.14%169.44%
May 10, 2022Tejas SavantMorgan Stanley$350.00$219.6759.33%161.96%
May 08, 2022Kyle MiksonCanaccord Genuity$520.00$249.05108.79%289.19%
Feb 21, 2022David WestenbergPiper Sandler$460.00$311.9747.45%244.29%
Feb 14, 2022Dan BrennanCowen & Co.$562.00$329.4570.59%320.63%
Jan 23, 2022Daniel AriasStifel Nicolaus$480.00$365.9431.17%259.25%
Jan 11, 2022Luke SergottBarclays$400.00$423.80-5.62%199.38%
Jan 06, 2022Patrick B DonnellyCitigroup$400.00$378.935.56%199.38%
Jan 06, 2022Tejas SavantMorgan Stanley$425.00$378.9312.16%218.09%
Aug 31, 2021Kyle Mikson CFACanaccord Genuity$555.00$457.1621.40%315.39%
Jun 01, 2021Vijay KumarEvercore ISI$400.00$407.45-1.83%199.38%

The latest Illumina stock forecast, released on Jan 10, 2025 by Eve Burstein from Bernstein, set a price target of $140.00, which represents a 2.42% increase from the stock price at the time of the forecast ($136.69), and a 4.78% increase from ILMN last price ($133.61).

Illumina Price Target by Period

1M3M12M
# Anlaysts2520
Avg Price Target$160.00$149.80$150.65
Last Closing Price$133.61$133.61$133.61
Upside/Downside19.75%12.12%12.75%

In the current month, the average price target of Illumina stock is $160.00, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 19.75% increase as opposed to Illumina's last price of $133.61. This month's average price target is up 6.81% compared to last quarter, and up 6.21% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025BernsteinMarket PerformMarket PerformHold
Jan 02, 2025Evercore ISIOutperformOutperformHold
Dec 11, 2024CitigroupBuyNeutralDowngrade
Nov 05, 2024Canaccord GenuityHoldHoldHold
Nov 05, 2024BarclaysPositivePositiveHold
Oct 17, 2024HSBCBuyUpgrade
Oct 15, 2024BarclaysEqual-WeightEqual-WeightHold
Oct 10, 2024UBSBuyBuyHold
Oct 02, 2024RBC CapitalOutperformOutperformHold
Aug 16, 2024BenchmarkBuyBuyHold
Aug 16, 2024DaiwaBuyUpgrade
Aug 15, 2024ScotiabankSector OutperformSector OutperformHold
Aug 14, 2024WedbushNeutralOutperformUpgrade
Aug 14, 2024Goldman SachsBuyUpgrade
Aug 14, 2024BarclaysUnderweightEqual-WeightUpgrade
Aug 14, 2024Cowen & Co.HoldBuyUpgrade
Aug 14, 2024Cowen & Co.HoldMixedUpgrade
Aug 14, 2024BarclaysUnderweightHoldUpgrade
Aug 13, 2024StephensUnderperformUnderperformHold
Aug 13, 2024UBSBuyBuyHold
Aug 07, 2024Cowen & Co.HoldHoldHold
Aug 07, 2024CitigroupBuyBuyHold
Aug 07, 2024BarclaysUnderweightUnderweightHold
Jul 30, 2024Piper SandlerOverweightOverweightHold
Jul 01, 2024StephensHoldHoldHold
Jun 11, 2024Evercore ISIOutperformOutperformHold
Jun 06, 2024Wolfe ResearchOutperformOutperformHold
Jun 06, 2024Cowen & Co.HoldHoldHold
Jun 03, 2024StephensSector OutperformSector OutperformHold
Jun 03, 2024ScotiabankUnderperformUnderperformHold
Jun 03, 2024JefferiesHoldInitialise
May 03, 2024StephensNeutralNeutralHold
Feb 14, 2024StephensBuyBuyHold
Dec 18, 2023ScotiabankSector PerformSector OutperformUpgrade
Dec 15, 2023BernsteinMarket PerformUpgrade
Dec 14, 2023StephensOverweightInitialise
Sep 29, 2023BarclaysUnderweightUnderweightHold
Mar 15, 2023RBC CapitalOutperformOutperformHold
Feb 10, 2023CFRASellUpgrade
Feb 08, 2023Piper SandlerOverweightOverweightHold
Feb 08, 2023RBC CapitalOutperformOutperformHold
Feb 08, 2023SVB LeerinkOutperformOutperformHold
Jan 10, 2023SVB LeerinkOutperformOutperformHold
Jan 05, 2023ScotiabankSector PerformInitialise
Dec 20, 2022OTR GlobalMixedPositiveUpgrade
Dec 07, 2022RBC CapitalOutperformInitialise
Nov 14, 2022Piper SandlerOverweightOverweightHold
Oct 04, 2022SVB LeerinkOutperformUpgrade
Oct 04, 2022Wells FargoEqual-WeightDowngrade
Oct 04, 2022WedbushNeutralDowngrade
Oct 04, 2022OppenheimerPerformDowngrade
Oct 04, 2022UBSBuyUpgrade
Oct 04, 2022Credit SuisseOutperformUpgrade
Oct 04, 2022CitigroupNeutralBuyUpgrade
Sep 29, 2022Piper SandlerOverweightOverweightHold
Sep 28, 2022OTR GlobalPositiveMixedDowngrade
Sep 28, 2022Evercore ISIOutperformUpgrade
Aug 12, 2022CitigroupNeutralNeutralHold
Jul 13, 2022Piper SandlerPositivePositiveHold
Jul 08, 2022CitigroupNeutralNeutralHold
May 15, 2022Piper SandlerOverweightOverweightHold
May 10, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Apr 26, 2022OTR GlobalPositiveUpgrade
Jan 12, 2022BarclaysUnderweightUpgrade

Illumina's last stock rating was published by Bernstein on Jan 10, 2025. The company gave ILMN a "Market Perform" rating, the same as its previous rate.

Illumina Financial Forecast

Illumina Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue----------------$1.12B-$1.18B$1.09B$1.20B$1.11B$1.16B$1.22B$953.00M$1.11B$1.13B$1.09B-$794.00M
Avg Forecast$1.29B$1.29B$1.26B$1.24B$1.21B$1.19B$1.17B$1.14B$1.15B$1.13B$1.10B$1.07B$1.08B$1.08B$1.09B$1.05B$1.09B$1.13B$1.16B$1.07B$1.07B$1.11B$1.22B$1.22B$1.13B$1.05B$1.02B$996.34M$903.91M$715.83M
High Forecast$1.33B$1.32B$1.29B$1.28B$1.24B$1.23B$1.20B$1.17B$1.18B$1.16B$1.13B$1.10B$1.10B$1.08B$1.09B$1.05B$1.12B$1.15B$1.19B$1.09B$1.09B$1.11B$1.22B$1.22B$1.13B$1.05B$1.02B$996.34M$903.91M$715.83M
Low Forecast$1.25B$1.25B$1.22B$1.21B$1.17B$1.16B$1.14B$1.10B$1.12B$1.09B$1.07B$1.04B$1.07B$1.08B$1.09B$1.05B$1.07B$1.10B$1.13B$1.03B$1.06B$1.11B$1.22B$1.22B$1.13B$1.05B$1.02B$996.34M$903.91M$715.83M
# Analysts444444443338108335136655511121110998
Surprise %----------------1.03%-1.01%1.02%1.12%1.00%0.95%1.00%0.85%1.06%1.11%1.10%-1.11%

Illumina's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.05B, with a low forecast of $1.05B, and a high forecast of $1.05B. ILMN's average Quarter revenue forecast represents a -6.39% decrease compared to the company's last Quarter revenue of $1.12B (Dec 23).

Illumina EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts444444443338108335136655511121110998
EBITDA----------------$-164.00M-$-88.00M$-64.00M$41.00M$4.15B$72.00M$237.00M$132.00M$-545.00M$187.00M$193.00M-$162.00M
Avg Forecast$-66.29M$-65.98M$-64.50M$-63.78M$-61.92M$-61.25M$-60.07M$-58.22M$-59.04M$-57.73M$-56.59M$-55.10M$-55.34M$-55.37M$-56.04M$232.60M$-55.75M$-58.02M$-59.50M$211.46M$113.74M$335.58M$369.07M$192.23M$340.22M$316.63M$170.00M$300.95M$273.03M$216.22M
High Forecast$-64.27M$-63.97M$-62.53M$-61.84M$-60.04M$-59.39M$-58.24M$-56.44M$-57.25M$-55.97M$-54.86M$-53.56M$-54.82M$-55.15M$-56.01M$279.12M$-54.72M$-56.55M$-57.69M$253.75M$136.49M$335.58M$369.07M$230.68M$340.22M$316.63M$204.00M$300.95M$273.03M$216.22M
Low Forecast$-68.04M$-67.72M$-66.20M$-65.46M$-63.55M$-62.87M$-61.65M$-59.75M$-60.60M$-59.25M$-58.08M$-56.65M$-56.36M$-55.59M$-56.07M$186.08M$-57.28M$-58.74M$-61.07M$169.17M$90.99M$335.58M$369.07M$153.79M$340.22M$316.63M$136.00M$300.95M$273.03M$216.22M
Surprise %----------------2.94%-1.48%-0.30%0.36%12.36%0.20%1.23%0.39%-1.72%1.10%0.64%-0.75%

6 analysts predict ILMN's average Quarter EBITDA for Mar 23 to be $211.46M, with a high of $253.75M and a low of $169.17M. This is 415.75% upper than Illumina's previous annual EBITDA (Dec 22) of $41.00M.

Illumina Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts444444443338108335136655511121110998
Net Income----------------$-176.00M-$-234.00M$3.00M$112.00M$-3.82B$-535.00M$86.00M$257.00M$317.00M$185.00M$147.00M-$179.00M
Avg Forecast$235.20M$252.80M$225.60M$228.80M$211.02M$216.62M$198.34M$192.87M$187.49M$184.84M$170.99M$161.31M$146.55M$140.58M$17.54M$84.40M$2.90M$23.19M$2.52M$76.73M$67.76M$44.23M$96.41M$69.76M$70.48M$203.26M$115.63M$214.57M$171.49M$125.63M
High Forecast$243.26M$261.46M$233.33M$236.64M$218.25M$224.04M$205.13M$199.47M$193.91M$191.17M$176.85M$181.47M$149.77M$140.93M$17.57M$101.29M$49.22M$38.65M$2.61M$92.08M$81.31M$44.23M$96.41M$83.71M$70.48M$205.89M$138.75M$214.57M$171.49M$125.63M
Low Forecast$225.89M$242.79M$216.67M$219.74M$202.66M$208.05M$190.48M$185.23M$180.07M$177.52M$164.22M$147.87M$143.33M$140.24M$17.50M$67.52M$-23.16M$-5.80M$2.42M$61.38M$54.21M$44.23M$96.41M$55.80M$70.48M$200.63M$92.50M$214.57M$171.49M$125.63M
Surprise %-----------------60.79%--92.81%0.04%1.65%-86.28%-5.55%1.23%3.65%1.56%1.60%0.69%-1.42%

Illumina's average Quarter net income forecast for Jun 23 is $2.52M, with a range of $2.42M to $2.61M. ILMN's average Quarter net income forecast represents a -15.96% decrease compared to the company's last Quarter net income of $3.00M (Mar 23).

Illumina SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts444444443338108335136655511121110998
SG&A----------------$485.00M-$450.00M$378.00M$426.00M$146.00M$410.00M$308.00M$298.00M$879.00M$413.00M$374.00M-$192.00M
Avg Forecast$421.33M$419.37M$409.92M$405.36M$393.56M$389.31M$381.79M$370.01M$375.27M$366.90M$359.66M$350.23M$351.70M$351.90M$356.18M$302.28M$354.32M$368.79M$378.15M$274.80M$257.73M$356.00M$391.53M$249.82M$360.93M$335.89M$258.13M$319.26M$289.64M$229.38M
High Forecast$432.43M$430.42M$420.72M$416.04M$403.93M$399.57M$391.85M$379.76M$385.16M$376.57M$369.14M$360.05M$358.22M$353.29M$356.38M$362.74M$364.07M$373.33M$388.12M$329.77M$309.28M$356.00M$391.53M$299.79M$360.93M$335.89M$309.75M$319.26M$289.64M$229.38M
Low Forecast$408.49M$406.60M$397.44M$393.01M$381.58M$377.45M$370.16M$358.74M$363.84M$355.72M$348.71M$340.41M$348.45M$350.51M$355.99M$241.83M$347.82M$359.43M$366.63M$219.84M$206.18M$356.00M$391.53M$199.86M$360.93M$335.89M$206.50M$319.26M$289.64M$229.38M
Surprise %----------------1.37%-1.19%1.38%1.65%0.41%1.05%1.23%0.83%2.62%1.60%1.17%-0.84%

Illumina's average Quarter SG&A projection for Mar 24 is $302.28M, based on 3 Wall Street analysts, with a range of $241.83M to $362.74M. The forecast indicates a -37.67% fall compared to ILMN last annual SG&A of $485.00M (Dec 23).

Illumina EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts444444443338108335136655511121110998
EPS----------------$-1.11-$-1.48$0.02$0.71$-24.31$-3.41$0.55$1.76$2.09$1.27$1.01-$1.22
Avg Forecast$1.47$1.58$1.41$1.43$1.32$1.35$1.24$1.21$1.17$1.16$1.07$1.01$0.92$0.88$0.11$0.04$0.02$0.14$0.02$0.01$0.26$0.28$0.61$0.87$0.44$1.28$1.32$1.35$1.08$0.79
High Forecast$1.52$1.63$1.46$1.48$1.36$1.40$1.28$1.25$1.21$1.19$1.11$1.13$0.94$0.88$0.11$0.04$0.31$0.24$0.02$0.01$0.26$0.28$0.61$0.87$0.44$1.29$1.32$1.35$1.08$0.79
Low Forecast$1.41$1.52$1.35$1.37$1.27$1.30$1.19$1.16$1.13$1.11$1.03$0.92$0.90$0.88$0.11$0.04$-0.14$-0.04$0.02$0.01$0.25$0.28$0.61$0.87$0.44$1.26$1.32$1.35$1.08$0.79
Surprise %-----------------61.34%--93.92%3.71%2.76%-87.39%-5.62%0.63%3.97%1.63%0.96%0.75%-1.54%

According to 6 Wall Street analysts, Illumina's projected average Quarter EPS for Jun 23 is $0.02, with a low estimate of $0.02 and a high estimate of $0.02. This represents a -21.21% decrease compared to ILMN previous annual EPS of $0.02 (Mar 23).

Illumina Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CDNACareDx$22.84$37.5064.19%Buy
EXASExact Sciences$55.41$77.0038.96%Buy
IDXXIDEXX Laboratories$417.86$479.7514.81%Buy
DHRDanaher$247.84$283.8614.53%Buy
ILMNIllumina$133.61$150.0012.27%Buy
TMOThermo Fisher Scientific$584.29$631.718.12%Buy
AAgilent$150.34$150.500.11%Buy
NTRANatera$168.08$154.80-7.90%Buy
WATWaters$413.48$371.00-10.27%Buy
TWSTTwist Bioscience$51.86$46.00-11.30%Buy

ILMN Forecast FAQ

Is Illumina a good buy?

Yes, according to 22 Wall Street analysts, Illumina (ILMN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 15 'Buy' recommendations, accounting for 68.18% of ILMN's total ratings.

What is ILMN's price target?

Illumina (ILMN) average price target is $150 with a range of $58 to $195, implying a 12.27% from its last price of $133.61. The data is based on 22 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Illumina stock go up soon?

According to Wall Street analysts' prediction for ILMN stock, the company can go up by 12.27% (from the last price of $133.61 to the average price target of $150), up by 45.95% based on the highest stock price target, and down by -56.59% based on the lowest stock price target.

Can Illumina stock reach $200?

ILMN's average twelve months analyst stock price target of $150 does not support the claim that Illumina can reach $200 in the near future.

What is Illumina's current price target trend?

2 Wall Street analysts forecast a $160 price target for Illumina (ILMN) this month, up 19.75% from its last price of $133.61. Compared to the last 3 and 12 months, the average price target increased by 12.12% and increased by 12.75%, respectively.

What are Illumina's analysts' financial forecasts?

Illumina's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.71B (high $4.83B, low $4.57B), average EBITDA is $-241M (high $-234M, low $-248M), average net income is $818.85M (high $846.9M, low $786.42M), average SG&A $1.53B (high $1.58B, low $1.49B), and average EPS is $5.12 (high $5.29, low $4.92). ILMN's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $5.08B (high $5.22B, low $4.93B), average EBITDA is $-261M (high $-253M, low $-267M), average net income is $942.4M (high $974.68M, low $905.08M), average SG&A $1.66B (high $1.7B, low $1.61B), and average EPS is $5.89 (high $6.09, low $5.66).

Did the ILMN's actual financial results beat the analysts' financial forecasts?

Based on Illumina's last annual report (Dec 2023), the company's revenue was $4.58B, beating the average analysts forecast of $4.45B by 3.11%. Apple's EBITDA was $4.89B, beating the average prediction of $38.19M by 12697.53%. The company's net income was $-4.404B, missing the average estimation of $105.34M by -4280.88%. Apple's SG&A was $1.3B, missing the average forecast of $1.38B by -5.75%. Lastly, the company's EPS was $-28.05, missing the average prediction of $0.184 by -15330.00%. In terms of the last quarterly report (Dec 2023), Illumina's revenue was $1.12B, beating the average analysts' forecast of $1.09B by 3.19%. The company's EBITDA was $-164M, beating the average prediction of $-55.748M by 194.18%. Illumina's net income was $-176M, missing the average estimation of $2.9M by -6178.69%. The company's SG&A was $485M, beating the average forecast of $354.32M by 36.88%. Lastly, the company's EPS was $-1.11, missing the average prediction of $0.0181 by -6233.95%